Blood cancer Clinical Trials in Ann Arbor, MI

As of July 2026, 43 paid clinical trials are recruiting for Blood cancer in Ann Arbor, Michigan. Blood cancer trials investigate CAR-T cell therapies, bispecific antibodies, BTK and BCL-2 inhibitors, and novel combinations across leukemias, lymphomas, myeloma, and myelodysplastic syndromes. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 17, 2026.

Filter results

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

44 clinical trials for Blood cancer

·Clear filters·↓ Download CSV

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

for Lymphoma, Non-Hodgkin

Sites in Ann Arbor +22 more locations

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT07101328·Phase 1·Recruiting·Listed Aug 2025

Apply to this trial

AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma

for Multiple Myeloma

Sites in Ann Arbor +7 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06106945·Phase 1, Phase 2·Recruiting·Listed Oct 2023

Apply to this trial

A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)

for Multiple Myeloma

Drug: Belantamab mafodotin

Sites in Ann Arbor, Detroit +28 more locations

Sponsor: GlaxoSmithKline

Sex: All·Age: 18+

Code: NCT06679101·Phase 3·Recruiting·Listed Nov 2024

Apply to this trial

Conditions in Blood cancer (Ann Arbor, MI)

Hematologic malignancy· 11 Acute myeloid leukemia (AML)· 9 Non-Hodgkin lymphoma· 8 Multiple myeloma· 7 Myelofibrosis· 6 Leukemia (other)· 4 Myelodysplastic syndromes (MDS)· 4 Mantle cell lymphoma· 4 Hodgkin lymphoma· 3 Chronic lymphocytic leukemia (CLL)· 2 Acute lymphoblastic leukemia· 2 Myeloproliferative neoplasm· 2 Follicular lymphoma· 2 Diffuse large B-cell lymphoma (DLBCL)· 1 Marginal zone lymphoma· 1 Small lymphocytic lymphoma· 1